Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 14, 2020 06:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder

Rapid, durable, and statistically significant improvement demonstrated in patient-reported depressive symptoms, as measured by the QIDS-SR-16 total score compared to placebo (p=0.001) Clinical...
December 13, 2016 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM® Biotech Expands Advisory Board With Psychiatry Specialist – Dr. Ilya Reznik

NEW YORK, Dec. 13, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, announces the addition to its advisory...